Can Mira be used with HRT?Updated a month ago
Mira can be used to monitor patients using HRT, but it is important to understand how different types of HRT affect Mira data. Effective monitoring of hormone therapy requires more than symptom improvement or interpretation of a single hormone value. Mira enables a multidimensional evaluation of treatment response by integrating three key indicators:
- Symptom improvement
- Estrogen trend changes (as a proxy for therapy absorption)
- Longitudinal FSH feedback.
Symptom improvement reflects patient comfort, quality of life, and treatment tolerability, but alone does not confirm physiologic hormone response.
Mira E3G trend changes can provide supportive insight into estrogen exposure, helping clinicians determine whether therapy is being absorbed and influencing hormonal coordination. Mira E3G should not be used to guide dose adjustments in isolation.
FSH stabilization or reduction offers a critical physiologic context by reflecting ovarian–pituitary feedback and may indicate a meaningful biologic response beyond symptom relief alone.
When these three domains move in a favorable direction together — improved symptoms, supportive estrogen trend changes, and stabilization or suppression of FSH — clinicians gain greater confidence that therapy is both clinically effective and physiologically supportive. This pattern-based approach allows Mira to complement traditional monitoring methods while providing deeper insight into treatment response across perimenopause and menopause.
Read the full Guide to Perimenopause and Menopause using Mira here.